$18.35
-1.12-5.75%
Últ. Act.: Oct 30, 5:28 PM
Relay Therapeutics (RLAY) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.40 | $-0.36 | $-0.39 | $-0.41 |
| Actual | $-0.41 | $-0.41 | $-0.32 | $-0.43 |
| Surprise | -2.50% | -13.9% | +17.9% | -4.88% |
| Revenue | ||||
| Estimate | $1.0M | $6.8M | $8.6M | $332000 |
| Actual | $350000 | $3.0M | $7.0M | $0 |
| Surprise | -66.0% | -55.8% | -18.1% | -100.0% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.40 | $-0.38 | $-0.41 | $-0.42 |
| Revenue | ||||
| Consensus | $1.4M | $7.4M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.41 | $-0.40 | -2.50 % |
| Q1 | May 5, 2026 | $-0.41 | $-0.36 | -13.9 % |
| Q4 | Feb 26, 2026 | $-0.32 | $-0.39 | 17.9 % |
| Q3 | Nov 6, 2025 | $-0.43 | $-0.41 | -4.88 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $350.00K | $1.03M | -66.0 % |
| Q1 | May 5, 2026 | $3.00M | $6.79M | -55.8 % |
| Q4 | Feb 26, 2026 | $7.00M | $8.55M | -18.1 % |
| Q3 | Nov 6, 2025 | $0 | $332.00K | -100.0 % |